# Shandong Haiyu Biology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shandong-haiyu-biology-co

- Industry: Pharmaceuticals
- Headquarters: Jining, China
- Website: www.haiyu58.com
- Latest round: Series A (Aug 1, 2015)
- Investors on record: 1

## About

Established in 2005 and based in Jinan, Shandong Haiyu Biology Co., Ltd operates as a healthcare drug developer dedicated to providing medicines and health products. It has over 200 employees. The company has 1 international patent, 46 domestic patents, 17 invention patents, and 26 utility model patents. It also acquired certifications such as ISO9001 and HACCP. In August 2015, the company closed series A funding from new investor Harlyn Capital. In May 2016, Shandong Haiyu Biology Co., Ltd was listed on the New Third Board.

The company mainly provides products related to pharmaceutical intermediates, health supplements, functional cosmetics, and other fields. It has developed a series of products including chondroitin sulfate, kumari health tablet sugar, bone density enhancing gel, Qingtang Heyun, and collagen capsules.

In 2022, the company's revenue was CNY 217.47 million, and its net income was CNY 21.44 million.

## Funding rounds

- Series A, Aug 1, 2015 — Harlyn Capital

## Investors

- Harlyn Capital (https://capitalatlas.ai/funds/harlyn-capital) — Series A